Cholinergic and peptidergic systems in PSP.
PSP is associated with a widespread cholinergic deficit likely corresponding to a loss in cholinergic neurons. The cholinergic damage dramatically affects the basal ganglia and specific cell groups of the mesencephalon and pons. This provides an anatomically defined basis for motor and supranuclear oculomotor syndromes characteristic of PSP. Unlike Alzheimer's disease and Parkinson's disease with dementia, the disease is not associated with a marked cholinergic deficiency in the cerebral cortex. Various peptides are present at normal concentrations in extrapyramidal and limbic subcortical areas in brains of patients with PSP. Of particular interest, is somatostatin, the levels of which are subnormal in cerebral cortex of patients with dementia of Alzheimer' or Parkinson's disease type.
Javoy-Agid
F
F
INSERM U 289, Hôpital de la Salpêtrière, Paris, France.
D000109:Acetylcholine / Q000502:physiology*; D006801:Humans; D009474:Neurons / Q000502:physiology*; D009479:Neuropeptides / Q000502:physiology*; D013494:Supranuclear Palsy, Progressive / Q000473:pathology / Q000503:physiopathology*
D009479:Neuropeptides; D000109:Acetylcholine